tiprankstipranks
Advertisement
Advertisement
NurExone Adds Healthcare Heavyweight Eyal Gabbai to Board as It Advances Exosome Platform
PremiumCompany AnnouncementsNurExone Adds Healthcare Heavyweight Eyal Gabbai to Board as It Advances Exosome Platform
2M ago
NurExone Exosomes Show Strong Anti-Inflammatory Effect, Outperform Commercial Rival in Lab Tests
Premium
Company Announcements
NurExone Exosomes Show Strong Anti-Inflammatory Effect, Outperform Commercial Rival in Lab Tests
3M ago
NurExone Advances ExoPTEN Manufacturing for Future Clinical Trials
Premium
Company Announcements
NurExone Advances ExoPTEN Manufacturing for Future Clinical Trials
4M ago
NurExone to Showcase Exosome Therapy Leadership at Precision EV Forum
PremiumCompany AnnouncementsNurExone to Showcase Exosome Therapy Leadership at Precision EV Forum
5M ago
NurExone’s ExoPTEN Shows Promising Results in Glaucoma Treatment
Premium
Company Announcements
NurExone’s ExoPTEN Shows Promising Results in Glaucoma Treatment
6M ago
NurExone Biologic to Establish U.S. Manufacturing Facility in Indiana
Premium
Company Announcements
NurExone Biologic to Establish U.S. Manufacturing Facility in Indiana
6M ago
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
PremiumCompany AnnouncementsNurExone’s Exosomes Outperform Industry Standards in Healing Potential
8M ago
NurExone Biologic Finalist in Falling Walls Venture 2025
Premium
Company Announcements
NurExone Biologic Finalist in Falling Walls Venture 2025
8M ago
NurExone’s ExoPTEN Shows Promising Preclinical Results in Spinal Cord Injury Model
Premium
Company Announcements
NurExone’s ExoPTEN Shows Promising Preclinical Results in Spinal Cord Injury Model
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100